No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.

Saved in:
Bibliographic Details
Title: No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
Authors: Castaño-Bonilla T; Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Barragán E; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Sargas C; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Sanz A; Hematology Department, Hospital HM Sanchinarro, Madrid, Spain., Algarra L; Hematology Department, Hospital General Universitario de Albacete, Albacete, Spain., Herrera-Puente P; Hematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., García-Boyero R; Hematology Department, Hospital General de Castellón, Castellón de la Plana, Spain., Barrios M; Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain., Martinez-Cuadron D; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Rodriguez-Veiga R; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Boluda B; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Gil C; Hematology Department, Hospital General Universitario de Alicante, Alicante, Spain., Serrano-López J; Hematology Department, Hospital Universitario Reina Sofía, Córdoba, Spain., Martínez-López J; Hematology Department, Hospital Universitario Doce de Octubre, Madrid, Spain., Sayas-Lloris MJ; Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain., Olave MT; Hematology Department, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain., Riaza-Grau R; Hematology Department, Hospital Universitario Severo Ochoa, Madrid, Spain., Castillo TB; Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Larrayoz MJ; Molecular Biology Department, Cimalab Diagnosis, Clínica Universitaria de Navarra, Pamplona, Spain., Amigo R; Biobanco La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Jiménez-Velasco A; Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain., Sánchez J; Hematology Department, Hospital Universitario Reina Sofía, Córdoba, Spain., Ayala R; Hematology Department, Hospital Universitario Doce de Octubre, Madrid, Spain., Blas C; Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Lainez D; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Serrano-López J; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Sanz MA; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Alonso-Domínguez JM; Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; Instituto de Investigación Sanitaria (IIS-FJD), Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Montesinos P; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Source: Disease markers [Dis Markers] 2022 Aug 23; Vol. 2022, pp. 3132941. Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 8604127 Publication Model: eCollection Cited Medium: Internet ISSN: 1875-8630 (Electronic) Linking ISSN: 02780240 NLM ISO Abbreviation: Dis Markers Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1875-8630
DOI:10.1155/2022/3132941